PDB Short entry for 2B1V HEADER HORMONE/GROWTH FACTOR RECEPTOR 16-SEP-05 2B1V TITLE HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH TITLE 2 OBCP-1M AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II TITLE 3 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: ER, ESTRADIOL RECEPTOR, ER-ALPHA; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 2; COMPND 10 CHAIN: C, D; COMPND 11 FRAGMENT: RESIDUES 686 - 698; COMPND 12 SYNONYM: NCOA-2, TRANSCRIPTIONAL INTERMEDIARY FACTOR 2; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: MCSG7 (PET12-DERIVATIVE); SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN HUMANS. KEYWDS ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.S.RAJAN,R.W.HSIEH,S.K.SHARMA,G.L.GREENE REVDAT 7 23-AUG-23 2B1V 1 REMARK REVDAT 6 20-OCT-21 2B1V 1 REMARK SEQADV REVDAT 5 24-JUL-19 2B1V 1 REMARK LINK REVDAT 4 13-JUL-11 2B1V 1 VERSN REVDAT 3 24-FEB-09 2B1V 1 VERSN REVDAT 2 11-JUL-06 2B1V 1 JRNL REVDAT 1 09-MAY-06 2B1V 0 JRNL AUTH R.W.HSIEH,S.S.RAJAN,S.K.SHARMA,Y.GUO,E.R.DESOMBRE,M.MRKSICH, JRNL AUTH 2 G.L.GREENE JRNL TITL IDENTIFICATION OF LIGANDS WITH BICYCLIC SCAFFOLDS PROVIDES JRNL TITL 2 INSIGHTS INTO MECHANISMS OF ESTROGEN RECEPTOR SUBTYPE JRNL TITL 3 SELECTIVITY. JRNL REF J.BIOL.CHEM. V. 281 17909 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16648639 JRNL DOI 10.1074/JBC.M513684200 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.97 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 44059 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2346 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3058 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.02 REMARK 3 BIN R VALUE (WORKING SET) : 0.2360 REMARK 3 BIN FREE R VALUE SET COUNT : 181 REMARK 3 BIN FREE R VALUE : 0.3000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4005 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 91 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.24000 REMARK 3 B22 (A**2) : -0.23000 REMARK 3 B33 (A**2) : 0.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.17000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.146 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.135 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.086 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.504 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4146 ; 0.005 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5593 ; 0.927 ; 2.002 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 492 ; 4.143 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 174 ;35.297 ;24.080 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 781 ;14.466 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;22.314 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 658 ; 0.064 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2945 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2081 ; 0.217 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2885 ; 0.315 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 308 ; 0.150 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 50 ; 0.205 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 7 ; 0.311 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2562 ; 1.983 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4012 ; 2.708 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1752 ; 4.801 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1581 ; 6.487 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 2 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 305 A 548 4 REMARK 3 1 B 305 B 547 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1875 ; 0.60 ; 0.50 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1875 ; 2.29 ; 2.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : C D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 C 688 C 696 4 REMARK 3 1 D 688 D 696 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 2 C (A): 79 ; 0.65 ; 0.50 REMARK 3 MEDIUM THERMAL 2 C (A**2): 79 ; 1.94 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 305 A 548 REMARK 3 ORIGIN FOR THE GROUP (A): 12.8780 0.3963 -1.5670 REMARK 3 T TENSOR REMARK 3 T11: -0.0498 T22: -0.0728 REMARK 3 T33: -0.0501 T12: 0.0028 REMARK 3 T13: 0.0236 T23: 0.0033 REMARK 3 L TENSOR REMARK 3 L11: 0.9232 L22: 1.0206 REMARK 3 L33: 1.5517 L12: -0.0924 REMARK 3 L13: 0.4773 L23: -0.2144 REMARK 3 S TENSOR REMARK 3 S11: -0.0217 S12: 0.0395 S13: -0.0463 REMARK 3 S21: -0.1108 S22: 0.0076 S23: 0.0383 REMARK 3 S31: 0.0239 S32: 0.0147 S33: 0.0141 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 305 B 549 REMARK 3 ORIGIN FOR THE GROUP (A): 4.6839 -0.0577 22.0067 REMARK 3 T TENSOR REMARK 3 T11: -0.0387 T22: -0.0650 REMARK 3 T33: -0.0758 T12: -0.0028 REMARK 3 T13: 0.0106 T23: -0.0085 REMARK 3 L TENSOR REMARK 3 L11: 1.2914 L22: 0.9003 REMARK 3 L33: 0.7761 L12: 0.1447 REMARK 3 L13: -0.3590 L23: -0.2355 REMARK 3 S TENSOR REMARK 3 S11: 0.0391 S12: -0.1054 S13: 0.0402 REMARK 3 S21: 0.0861 S22: -0.0184 S23: 0.0777 REMARK 3 S31: -0.0428 S32: 0.0475 S33: -0.0207 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 688 C 696 REMARK 3 ORIGIN FOR THE GROUP (A): 9.0176 -16.8736 -10.8662 REMARK 3 T TENSOR REMARK 3 T11: 0.2398 T22: -0.0273 REMARK 3 T33: 0.0723 T12: -0.0085 REMARK 3 T13: 0.0010 T23: -0.0837 REMARK 3 L TENSOR REMARK 3 L11: 28.0518 L22: 10.4485 REMARK 3 L33: 8.4690 L12: -6.6740 REMARK 3 L13: 0.4037 L23: 2.2534 REMARK 3 S TENSOR REMARK 3 S11: 0.2321 S12: 0.7435 S13: -1.1753 REMARK 3 S21: -0.5714 S22: -0.2829 S23: 0.2920 REMARK 3 S31: 1.5038 S32: 0.2707 S33: 0.0509 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 688 D 696 REMARK 3 ORIGIN FOR THE GROUP (A): -5.3064 16.3198 27.4677 REMARK 3 T TENSOR REMARK 3 T11: 0.1082 T22: -0.0492 REMARK 3 T33: 0.0563 T12: -0.0197 REMARK 3 T13: 0.0832 T23: -0.0682 REMARK 3 L TENSOR REMARK 3 L11: 15.0132 L22: 11.8371 REMARK 3 L33: 1.0014 L12: -5.0456 REMARK 3 L13: -0.5261 L23: -2.9805 REMARK 3 S TENSOR REMARK 3 S11: 0.0380 S12: -0.3201 S13: 0.5754 REMARK 3 S21: 0.0396 S22: 0.0504 S23: 0.1951 REMARK 3 S31: -0.3772 S32: -0.1350 S33: -0.0884 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2B1V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-OCT-05. REMARK 100 THE DEPOSITION ID IS D_1000034571. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-AUG-05 REMARK 200 TEMPERATURE (KELVIN) : 77.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-BM-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : BENT GE(III) MONOCHROMATOR REMARK 200 OPTICS : BENT CONICAL SI-MIRROR (RH REMARK 200 COATED) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 135 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46440 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.0530 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.40700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.730 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: XTALVIEW REMARK 200 STARTING MODEL: PDB ENTRY 1ZKY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 8.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.96950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -47.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 298 REMARK 465 LYS A 299 REMARK 465 ARG A 300 REMARK 465 SER A 301 REMARK 465 LYS A 302 REMARK 465 LYS A 303 REMARK 465 ASN A 304 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 LEU A 469 REMARK 465 LEU A 549 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 465 ILE B 298 REMARK 465 LYS B 299 REMARK 465 ARG B 300 REMARK 465 SER B 301 REMARK 465 LYS B 302 REMARK 465 LYS B 303 REMARK 465 ASN B 304 REMARK 465 ARG B 548 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 THR B 553 REMARK 465 SER B 554 REMARK 465 LYS C 686 REMARK 465 HIS C 687 REMARK 465 SER C 697 REMARK 465 SER C 698 REMARK 465 LYS D 686 REMARK 465 HIS D 687 REMARK 465 SER D 697 REMARK 465 SER D 698 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 306 -38.43 -153.14 REMARK 500 LEU B 466 -31.94 106.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 458 A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 458 B 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ZKY RELATED DB: PDB REMARK 900 RELATED ID: 2B1V RELATED DB: PDB REMARK 900 RELATED ID: 2B1Z RELATED DB: PDB DBREF 2B1V A 298 554 UNP P03372 ESR1_HUMAN 298 554 DBREF 2B1V B 298 554 UNP P03372 ESR1_HUMAN 298 554 DBREF 2B1V C 686 698 UNP Q15596 NCOA2_HUMAN 686 698 DBREF 2B1V D 686 698 UNP Q15596 NCOA2_HUMAN 686 698 SEQADV 2B1V CME A 381 UNP P03372 CYS 381 MODIFIED RESIDUE SEQADV 2B1V CME A 417 UNP P03372 CYS 417 MODIFIED RESIDUE SEQADV 2B1V CME A 530 UNP P03372 CYS 530 MODIFIED RESIDUE SEQADV 2B1V SER A 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 2B1V CME B 381 UNP P03372 CYS 381 MODIFIED RESIDUE SEQADV 2B1V CME B 417 UNP P03372 CYS 417 MODIFIED RESIDUE SEQADV 2B1V CME B 530 UNP P03372 CYS 530 MODIFIED RESIDUE SEQADV 2B1V SER B 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQRES 1 A 257 ILE LYS ARG SER LYS LYS ASN SER LEU ALA LEU SER LEU SEQRES 2 A 257 THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA GLU SEQRES 3 A 257 PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG PRO SEQRES 4 A 257 PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN LEU SEQRES 5 A 257 ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA LYS SEQRES 6 A 257 ARG VAL PRO GLY PHE VAL ASP LEU THR LEU HIS ASP GLN SEQRES 7 A 257 VAL HIS LEU LEU GLU CME ALA TRP LEU GLU ILE LEU MET SEQRES 8 A 257 ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY LYS SEQRES 9 A 257 LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN SEQRES 10 A 257 GLY LYS CME VAL GLU GLY MET VAL GLU ILE PHE ASP MET SEQRES 11 A 257 LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN LEU SEQRES 12 A 257 GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE LEU SEQRES 13 A 257 LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR LEU SEQRES 14 A 257 LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU SEQRES 15 A 257 ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA LYS SEQRES 16 A 257 ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU ALA SEQRES 17 A 257 GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SER SEQRES 18 A 257 ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CME LYS SEQRES 19 A 257 ASN VAL VAL PRO LEU SER ASP LEU LEU LEU GLU MET LEU SEQRES 20 A 257 ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 B 257 ILE LYS ARG SER LYS LYS ASN SER LEU ALA LEU SER LEU SEQRES 2 B 257 THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA GLU SEQRES 3 B 257 PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG PRO SEQRES 4 B 257 PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN LEU SEQRES 5 B 257 ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA LYS SEQRES 6 B 257 ARG VAL PRO GLY PHE VAL ASP LEU THR LEU HIS ASP GLN SEQRES 7 B 257 VAL HIS LEU LEU GLU CME ALA TRP LEU GLU ILE LEU MET SEQRES 8 B 257 ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY LYS SEQRES 9 B 257 LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN SEQRES 10 B 257 GLY LYS CME VAL GLU GLY MET VAL GLU ILE PHE ASP MET SEQRES 11 B 257 LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN LEU SEQRES 12 B 257 GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE LEU SEQRES 13 B 257 LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR LEU SEQRES 14 B 257 LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU SEQRES 15 B 257 ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA LYS SEQRES 16 B 257 ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU ALA SEQRES 17 B 257 GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SER SEQRES 18 B 257 ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CME LYS SEQRES 19 B 257 ASN VAL VAL PRO LEU SER ASP LEU LEU LEU GLU MET LEU SEQRES 20 B 257 ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 C 13 LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SER SEQRES 1 D 13 LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SER MODRES 2B1V CME A 381 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2B1V CME A 417 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2B1V CME A 530 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2B1V CME B 381 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2B1V CME B 417 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2B1V CME B 530 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 381 16 HET CME A 417 10 HET CME A 530 10 HET CME B 381 10 HET CME B 417 10 HET CME B 530 10 HET 458 A 201 19 HET 458 B 202 19 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM 458 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3- HETNAM 2 458 OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL FORMUL 1 CME 6(C5 H11 N O3 S2) FORMUL 5 458 2(C16 H20 O3) FORMUL 7 HOH *91(H2 O) HELIX 1 1 LEU A 306 LEU A 310 5 5 HELIX 2 2 THR A 311 GLU A 323 1 13 HELIX 3 3 SER A 338 LYS A 362 1 25 HELIX 4 4 GLY A 366 LEU A 370 5 5 HELIX 5 5 THR A 371 MET A 396 1 26 HELIX 6 6 ASN A 413 VAL A 418 5 6 HELIX 7 7 MET A 421 ASN A 439 1 19 HELIX 8 8 GLN A 441 SER A 456 1 16 HELIX 9 9 GLY A 457 PHE A 461 5 5 HELIX 10 10 GLU A 470 ALA A 493 1 24 HELIX 11 11 THR A 496 LYS A 531 1 36 HELIX 12 12 SER A 537 ALA A 546 1 10 HELIX 13 13 SER B 305 LEU B 310 1 6 HELIX 14 14 THR B 311 GLU B 323 1 13 HELIX 15 15 SER B 338 LYS B 362 1 25 HELIX 16 16 GLY B 366 LEU B 370 5 5 HELIX 17 17 THR B 371 SER B 395 1 25 HELIX 18 18 ARG B 412 LYS B 416 1 5 HELIX 19 19 GLY B 420 ASN B 439 1 20 HELIX 20 20 GLN B 441 SER B 456 1 16 HELIX 21 21 GLY B 457 PHE B 461 5 5 HELIX 22 22 LYS B 472 ALA B 493 1 22 HELIX 23 23 THR B 496 LYS B 531 1 36 HELIX 24 24 SER B 537 ALA B 546 1 10 HELIX 25 25 LYS C 688 ASP C 696 1 9 HELIX 26 26 LYS D 688 ASP D 696 1 9 SHEET 1 A 2 LYS A 401 ALA A 405 0 SHEET 2 A 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 B 2 LYS B 401 ALA B 405 0 SHEET 2 B 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 LINK C GLU A 380 N CME A 381 1555 1555 1.33 LINK C CME A 381 N ALA A 382 1555 1555 1.33 LINK C LYS A 416 N CME A 417 1555 1555 1.33 LINK C CME A 417 N VAL A 418 1555 1555 1.33 LINK C LYS A 529 N CME A 530 1555 1555 1.33 LINK C CME A 530 N LYS A 531 1555 1555 1.33 LINK C GLU B 380 N CME B 381 1555 1555 1.33 LINK C CME B 381 N ALA B 382 1555 1555 1.33 LINK C LYS B 416 N CME B 417 1555 1555 1.33 LINK C CME B 417 N VAL B 418 1555 1555 1.33 LINK C LYS B 529 N CME B 530 1555 1555 1.33 LINK C CME B 530 N LYS B 531 1555 1555 1.33 SITE 1 AC1 6 GLU A 353 LEU A 384 ARG A 394 PHE A 404 SITE 2 AC1 6 HIS A 524 LEU A 525 SITE 1 AC2 7 MET B 343 LEU B 346 GLU B 353 LEU B 384 SITE 2 AC2 7 ARG B 394 PHE B 404 HIS B 524 CRYST1 55.959 83.939 58.240 90.00 108.81 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017870 0.000000 0.006087 0.00000 SCALE2 0.000000 0.011913 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018139 0.00000